Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Showing posts with label hospital transmission. Show all posts
Showing posts with label hospital transmission. Show all posts

Tuesday, July 7, 2015

Canada: Retired nurse from Halton was shocked when she was diagnosed with Hep C

Halton residents asked to recognize World Hepatitis Day by tweeting
 
She spent most of her adult life working as an emergency room nurse and was looking forward to a less stressful retirement.

So the Halton resident never imagined a routine check-up with her family doctor would reveal she had contracted Hepatitis C.

“It came as a complete shock,” said the married woman with three adult sons. “I didn’t have any inkling I had this disease.

Read more...

Thursday, February 26, 2015

Transmission of Hepatitis C Virus Associated with Surgical Procedures — New Jersey 2010 and Wisconsin 2011

Morbidity and Mortality Weekly Report (MMWR)

February 27, 2015 / 64(07);165-170

Incidents of health care–associated hepatitis C virus (HCV) transmission that resulted from breaches in injection safety and infection prevention practices have been previously documented (1,2). During 2010 and 2011, separate, unrelated, occurrences of HCV infections in New Jersey and Wisconsin associated with surgical procedures were investigated to determine sources of HCV and mechanisms of HCV transmission. Molecular analyses of HCV strains and epidemiologic investigations indicated that transmission likely resulted from breaches of infection prevention practices. Health care and public health professionals should consider health care–associated transmission when evaluating acute HCV infections.

An estimated 3.2 million U.S. residents have chronic HCV infections; during 2011, approximately 16,500 acute HCV infections were diagnosed. Molecular analyses of HCV strains have enhanced investigations of health care–associated transmission (3–5) by determining the relatedness of strains infecting persons with acute and chronic HCV infection. Two investigations of HCV infection among patients who had surgical procedures highlight the potential for HCV contamination of medications or equipment, which can result in transmissions that are difficult to recognize.

Read more....